IART - Integra LifeSciences Holdings Corporation

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue992,075882,734796,717
Cost of Revenue349,089326,542302,946
Gross Profit642,986556,192493,771
Operating Expenses
Research Development58,15550,89543,559
Selling General and Administrative455,629415,757375,545
Non Recurring---
Total Operating Expenses---
Operating Income or Loss115,34079,58767,857
Income from Continuing Operations
Total Other Income/Expenses Net8694,618-324
Earnings Before Interest and Taxes116,20984,20567,533
Interest Expense25,80323,53421,967
Income Before Tax90,40660,67145,566
Income Tax Expense15,84253,8209,271
Minority Interest---
Net Income From Continuing Ops74,5646,85136,295
Non-recurring Events
Discontinued Operations--10,370-2,291
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income74,564-3,51934,004
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares74,564-3,51934,004